sinc
first
experi
thoma
e
starzl
liver
transplant
lt
revolution
treatment
patient
sever
liver
diseas
dramat
improv
outcom
illustr
success
procedur
around
transplant
perform
around
world
howev
access
lt
limit
stagnant
pool
donor
organ
contrast
increas
number
candid
franc
instanc
overal
number
newli
list
patient
increas
averag
transplant
candid
per
avail
regul
regard
alloc
system
led
graft
offer
patient
highest
risk
shortterm
mortal
consequ
sever
ill
patient
endstag
liver
diseas
esld
priorit
lt
increasingli
admit
intens
care
unit
icu
outcom
patient
esld
icu
use
concern
intensivist
due
outcom
compar
gener
popul
howev
improv
practic
led
outstand
point
shortterm
surviv
gain
liverspecif
reason
improv
fourfold
better
identif
candid
icu
admiss
base
specif
prognosi
score
better
understand
pathophysiolog
complic
chronic
liver
diseas
gener
improv
icu
care
develop
specif
manag
patient
advanc
liver
diseas
inde
last
decad
numer
medic
improv
manag
precipit
event
complic
esld
instanc
improv
administr
antimicrobi
therapi
bundl
care
sepsi
result
better
outcom
sepsi
septic
shock
among
other
use
vasopressor
antibiot
prophylaxi
endoscop
manag
result
signific
improv
prognosi
patient
admit
context
acut
varic
bleed
set
hepatoren
syndrom
hr
combin
use
albumin
infus
vasopressor
alongsid
clearer
diseas
definit
led
signific
improv
term
outcom
despit
improv
lt
remain
lifesav
procedur
patient
fail
recov
adequ
liver
function
order
illustr
import
urgent
lt
situat
share
polici
recent
implement
us
improv
equiti
access
lt
base
compar
outcom
observ
patient
high
meld
score
without
lt
patient
fulmin
hepat
failur
fhf
share
patient
esld
given
geograph
access
organ
patient
fhf
latter
group
still
grant
higher
alloc
statu
given
sever
unmet
medic
ethic
issu
face
clinician
order
optim
manag
patient
high
meld
score
perspect
lt
patient
categor
era
dual
concept
acuteonchron
liver
failur
aclf
mere
acut
decompens
prognosi
assess
use
context
perman
scarciti
resourc
prioriti
access
lt
manag
sever
ill
patient
given
potenti
increas
risk
postlt
mortal
upper
limit
sick
identifi
beyond
patient
list
lt
deal
patient
alreadi
list
less
sever
diseas
expos
brutal
deterior
liver
function
death
due
restrict
access
lt
final
identifi
manag
patient
candid
lt
recov
adequ
liver
function
herebi
offer
discuss
import
question
review
literatur
order
shed
light
manag
patient
high
meld
score
patient
high
meld
score
often
admit
context
acut
decompens
ie
ascit
gastrointestin
bleed
hepat
encephalopathi
andor
acut
bacteri
infect
distinct
made
mere
acut
decompens
aclf
regard
respect
outcom
mere
acut
decompens
associ
accept
mortal
respect
defin
either
absenc
organ
failur
of
presenc
cerebr
failur
serum
creatinin
level
mgdl
presenc
nonkidney
serum
creatinin
level
mgdl
encephalopathi
tabl
median
meld
patient
hospit
set
patient
high
meld
score
like
admit
context
aclf
world
gastroenterolog
organ
defin
aclf
syndrom
patient
chronic
liver
diseas
without
previous
diagnos
cirrhosi
character
acut
hepat
decompens
result
liver
failur
jaundic
prolong
intern
normal
ratio
extrahepat
of
associ
increas
mortal
within
period
day
month
definit
mortal
set
high
respect
around
three
type
aclf
defin
accord
absenc
type
presenc
type
b
cirrhosi
histori
previou
hepat
decompens
type
c
latter
preval
western
despit
agreement
definit
exact
implic
concept
acut
failur
remain
debat
among
differ
learn
societi
case
aclf
standard
liver
diseas
prognost
score
underestim
shortterm
mortal
close
associ
number
of
liver
failur
per
se
well
establish
patient
often
hospit
icu
icu
score
simplifi
acut
physiolog
score
ii
sequenti
organ
failur
assess
sofa
acut
physiolog
chronic
health
evalu
score
apach
evalu
extrahepat
of
better
predictor
mortal
meld
score
chronic
liver
failur
consortium
clifc
european
associ
studi
liver
diseas
easl
led
european
prospect
multicentr
centr
studi
involv
patient
hospit
acut
deterior
hepatocellular
function
order
establish
diagnost
criteria
aclf
assess
natur
histori
syndrom
canon
cohort
cohort
defin
adapt
sofa
clifc
author
propos
arbitrarili
threshold
ident
score
defin
of
accord
organ
system
includ
liver
coagul
kidney
brain
respir
circul
subsequ
grade
rang
absenc
aclf
depend
number
of
tabl
tabl
classif
identifi
popul
differ
prognos
illustr
mortal
rate
patient
aclf
grade
aclf
dynam
process
rapid
evolut
first
day
medic
care
associ
clinic
outcom
fig
identif
earli
nonsever
cours
resolut
aclf
aclf
grade
day
associ
low
moder
transplantfre
mortal
rang
contrari
earli
sever
cours
aclf
grade
day
associ
high
transplantfre
mortal
rang
therefor
sequenti
evalu
first
day
care
requir
order
optim
predict
outcom
subsequ
medic
manag
popul
score
deriv
clifc
name
clifc
aclf
addit
includ
age
logtransform
whiteblood
cell
count
initi
report
best
perform
predict
shortterm
mortal
popul
result
confirm
recent
studi
patient
aclf
work
clifc
aclf
fail
show
better
perfom
predict
day
mortal
compar
meld
auroc
vs
moreov
daili
use
seem
less
conveni
evalu
number
clifc
lactat
level
independ
associ
shortterm
mortal
critic
ill
patient
liver
cirrhosi
shown
significantli
improv
perform
clifc
aclf
modifi
call
clifc
aclfslact
score
remain
evalu
extern
togeth
numer
biomark
recent
associ
outcom
popul
combin
avail
score
biomark
could
optim
predict
event
popul
high
shortterm
mortal
accord
north
american
consortium
studi
liver
diseas
nacseld
aclf
syndrom
defin
extrahepat
of
among
follow
circulatori
failur
defin
shock
brain
failur
grade
iiiiv
hepat
encephalopathi
renal
failur
requir
renal
replac
therapi
respiratori
failur
requir
mechan
ventil
main
differ
definit
easlclif
consortium
stringent
definit
renal
failur
restrict
requir
renal
replac
therapi
absenc
liverrel
variabl
ie
bilirubin
intern
normal
ratio
patient
fulfil
aclf
definit
easlclif
consortium
enrol
princep
european
fulfil
nacseld
definit
larg
studi
publish
latter
includ
larg
multin
cohort
infect
noninfect
cirrhot
patient
nacseldaclf
independ
prognost
factor
surviv
number
of
also
associ
surviv
respect
around
substanti
proport
patient
high
meld
score
exclud
nacseldaclf
definit
due
stringent
definit
renal
failur
moreov
exclud
liverrel
variabl
could
includ
patient
without
high
meld
score
shall
therefor
hereaft
focu
patient
high
meld
score
hospit
context
aclf
accord
easlclif
consortium
classif
recommend
publish
guidelin
diagnosi
grade
aclf
base
assess
organ
function
defin
clifc
score
accord
data
daili
practic
prognosi
patient
high
meld
score
hospit
context
aclf
assess
grade
aclf
admiss
sequenti
evalu
day
day
appear
critic
order
character
cours
aclf
sever
vs
nonsever
optim
medic
manag
kidney
failur
patient
common
failur
report
canon
cohort
follow
liver
failur
patient
coagul
patient
brain
patient
circul
patient
lung
patient
impact
type
failur
shortterm
outcom
remain
debat
requir
vasopressor
mechan
ventil
identifi
failur
associ
worst
outcom
studi
wherea
report
larg
recent
intern
liver
failur
defin
total
bilirubin
mgdl
canon
studi
independ
predictor
sever
lifethreaten
cours
aclf
suggest
central
role
trigger
perpetu
factor
multiorgan
princep
studi
aclf
precipit
event
sepsi
alcohol
consumpt
gastrointestin
bleed
other
transjugular
portosystem
intrahepat
shunt
insert
surgeri
viral
hepat
multipl
precipit
event
report
popul
wherea
precipit
event
identifi
around
absenc
precipit
event
associ
differ
clinic
cours
absenc
precipit
event
thought
link
either
lack
sensit
diagnost
test
bacteri
infect
spontan
resolut
event
bacteri
transloc
episod
type
distribut
precipit
event
vari
accord
region
world
instanc
viral
hepat
repres
minor
identifi
precipit
event
canon
cohort
repres
event
larg
chines
type
precipit
event
relat
mortal
could
relat
mortal
divid
hepat
extrahepat
event
fig
subset
canon
databas
bacteri
infect
trigger
aclf
associ
poorer
outcom
aclf
trigger
sepsi
transplantfre
mortal
vs
p
studi
infect
multidrug
resist
bacteria
trigger
aclf
andor
sever
sepsissept
shock
diagnosi
associ
wors
therefor
accord
recent
recommend
easl
potenti
precipit
factor
either
hepat
ie
heavi
alcohol
intak
viral
hepat
druginduc
liver
injuri
autoimmun
hepat
andor
extrahepat
ie
infect
haemodynam
chang
follow
haemorrhag
surgeri
investig
earli
identif
treatment
particularli
bacteri
infect
popul
patient
high
meld
score
specif
treatment
avail
asid
antivir
therapi
patient
aclf
due
reactiv
hbv
infect
manag
mainli
base
organ
support
togeth
prevent
treatment
associ
complic
medic
care
requir
multidisciplinari
approach
includ
intensivist
specialist
infecti
diseas
transplant
team
made
hepatologist
surgeon
sever
prognosi
particularli
observ
aclf
grade
correspond
patient
high
meld
score
patient
prefer
manag
icu
lt
centr
recommend
easl
guidelin
earli
referr
patient
aclf
lt
centr
immedi
evalu
recommend
major
improv
prognosi
critic
ill
cirrhot
patient
observ
past
parallel
outcom
patient
aclf
shown
similar
patient
without
liver
diseas
admit
icu
sepsi
critic
therefor
opinion
access
icu
popul
deni
without
strong
evid
futil
care
assess
multidisciplinari
evalu
among
specif
bundl
care
popul
particular
effort
made
time
initi
resuscit
order
control
extens
multiorgan
failur
instanc
hour
delay
appropri
antimicrobi
therapi
associ
significantli
increas
hospit
mortal
moreov
prophylact
strategi
use
prevent
bacteri
infect
consid
deleteri
influenc
prognosi
set
aclf
trigger
noninfecti
gener
manag
patient
made
accord
recent
guidelin
expert
review
critic
ill
cirrhot
patient
review
focu
differ
altern
strategi
avail
popul
absenc
effect
altern
strategi
lt
remain
uniqu
cur
treatment
avail
popul
grant
prioriti
access
inde
meld
score
first
propos
predict
mortal
cirrhot
patient
transjugular
portosystem
intrahepat
shunt
later
score
wide
implement
graft
alloc
score
priorit
patient
disclos
highest
risk
wait
list
mortal
thu
lead
sickest
first
polici
surviv
benefit
confer
recipi
lt
increas
progress
meld
score
compar
candid
lt
wait
list
lower
threshold
meld
identifi
patient
benefit
lt
well
establish
around
could
vari
accord
aetiolog
underli
liver
diseas
nevertheless
maximum
benefit
lt
constantli
observ
sickest
patient
highest
meld
score
ie
meld
current
cap
wait
list
mortal
continu
increas
score
penal
transplant
candid
cap
despit
obviou
theoret
benefit
procedur
perform
lt
patient
high
meld
score
hospit
context
aclf
remain
controversi
inde
studi
report
increas
mortal
morbid
lt
recipi
high
meld
score
compar
popul
lower
meld
score
wherea
other
context
global
organ
shortag
lt
concept
util
therefor
oppos
one
rais
sever
unsolv
issu
link
question
result
lt
patient
high
meld
score
identif
sick
transplant
patient
associ
upper
limit
sickest
first
polici
recent
year
notion
futil
lt
use
posttranspl
mortal
higher
wait
list
mortal
case
inhospit
mortal
lt
howev
author
recent
review
prefer
correct
futil
lt
potenti
inappropri
lt
thu
reduc
valu
judgment
inher
term
futil
semant
chang
follow
adopt
new
term
multisocieti
statement
provid
guidanc
clinician
prevent
manag
disput
regard
patient
advanc
critic
chang
introduc
element
uncertainti
area
ie
potenti
consid
fact
medicin
alway
evolv
upper
limit
alway
term
potenti
inappropri
lt
therefor
prefer
futil
lt
identif
variabl
associ
postlt
outcom
set
patient
high
meld
help
identifi
clinic
situat
lt
potenti
inappropri
meld
alon
show
good
enough
perform
identifi
patient
high
rate
shortterm
postlt
mortal
even
sever
patient
use
uncap
meld
score
therefor
mani
author
search
recipi
factor
associ
mortal
inhospit
mortal
thirteen
variabl
identifi
retrospect
studi
patient
unit
network
organ
share
uno
lead
develop
psoft
prealloc
surviv
outcom
follow
liver
transplant
soft
score
inclus
graft
relat
variabl
show
good
perform
predict
postlt
mortal
cstatist
respect
bar
balanc
risk
score
develop
base
patient
uno
databas
identif
simpl
recipi
variabl
age
meld
life
support
pretransplant
retransplant
donorrel
variabl
associ
postlt
score
show
similar
perform
predict
postlt
mortal
cstatist
aclfscor
identifi
recipi
characterist
age
gender
esld
hepatocellular
carcinoma
recent
infect
presenc
aclf
donor
characterist
gender
independ
associ
mortal
month
score
also
show
compar
predict
perform
cstatist
test
apart
age
none
score
contain
variabl
evalu
comorbid
variou
diseas
comorbid
associ
outcom
screen
signific
extrahepat
comorbid
condit
cornerston
health
assess
requir
placement
wait
list
ucla
score
develop
aim
identifi
variabl
associ
inhospit
mortal
lt
patient
high
meld
score
among
evalu
variabl
author
chose
charlsoncomorbid
index
cci
alreadi
proven
recalibr
form
effici
determin
outcom
lt
anoth
score
name
cardiac
risk
score
defin
presenc
least
follow
variabl
sever
valvular
diseas
coronari
arteri
diseas
stenosi
previou
revascular
histori
myocardi
infarct
histori
ventricular
andor
atrial
arrhythmia
elev
preorthotop
lt
troponin
ngml
andor
new
wall
motion
abnorm
echocardiographi
inde
cardiovascular
diseas
shown
associ
shortterm
outcom
particularli
first
month
follow
lt
mortal
cardiovascular
event
meld
score
pretranspl
septic
shock
also
ageadjust
cci
cardiac
risk
score
associ
outcom
use
multivari
analysi
final
score
name
ucla
futil
risk
score
uclafr
import
weight
given
comorbid
includ
cardiac
risk
index
cci
uclafr
meld
score
cci
cci
cardiac
risk
cardiac
risk
septic
shock
septic
shock
recent
studi
report
result
lt
patient
of
score
seem
help
select
candid
lt
consid
predict
observ
postlt
surviv
anoth
studi
aim
compar
avail
score
independ
cohort
transplant
patient
high
meld
score
swiss
uno
cohort
predict
score
show
low
posit
predict
valu
posttranspl
mortal
despit
good
specif
among
score
bar
score
score
linearli
associ
use
score
design
critic
ill
patient
seem
restrict
popul
base
perform
tabl
emerg
concept
hepatolog
frailti
frailti
correspond
valid
geriatr
construct
increas
vulner
physiolog
stressor
frailti
repres
condit
given
patient
unlik
revers
liver
function
return
take
long
revers
patient
highli
vulner
postop
complic
mani
tool
assess
frailti
propos
evalu
esld
particularli
patient
await
lt
fri
frailti
index
short
physic
perform
batteri
minut
walk
activ
daili
live
karnofski
perform
statusbas
score
recent
propos
predict
death
hospit
discharg
subgroup
patient
low
meld
score
high
frailti
may
deriv
greatest
benefit
implement
howev
function
test
evalu
frailti
could
enough
discrimin
homogen
popul
high
meld
patient
moreov
may
possibl
perform
test
patient
clinic
condit
interest
approach
use
altern
test
evalu
frailti
better
adapt
icu
popul
requir
function
assess
evalu
surrog
marker
frailti
sarcopenia
assess
imag
repres
altern
option
associ
meld
ctscan
assess
sarcopenia
demonstr
use
identif
patient
highest
risk
mortal
wait
moreov
sarcopenia
associ
postlt
mortal
independ
meld
result
confirm
recent
differ
threshold
women
fatfre
muscl
mass
assess
mri
decompens
patient
associ
mortal
also
develop
aclf
howev
data
lack
regard
impact
sarcopenia
posttranspl
outcom
patient
high
meld
score
context
aclf
sarcopenia
evolv
process
evalu
readili
perform
view
assess
sarcopenia
ultrasonographi
seem
easi
reliabl
option
yet
evalu
cirrhot
present
time
identif
potenti
inappropri
lt
candid
base
sole
avail
score
consid
statist
perform
howev
combin
score
well
evalu
frailti
could
improv
clinic
manag
patient
high
meld
score
candid
lt
data
outcom
patient
aclf
treat
liver
lt
less
scarc
postlt
surviv
recipi
much
higher
anticip
patient
transplant
inde
canon
studi
patient
transplant
aclf
grade
day
day
n
better
surviv
nontranspl
patient
vs
p
similarli
report
experi
patient
transplant
aclf
grade
time
lt
better
surviv
match
control
vs
p
larg
cohort
studi
uno
perform
patient
transplant
of
good
surviv
rang
of
report
moreov
recipi
longterm
surviv
accept
rang
similar
result
liver
graft
regard
impact
type
of
postlt
outcom
lower
postlt
surviv
among
intub
patient
patient
circulatori
failur
type
patient
surviv
vs
levesqu
et
al
recent
report
wors
outcom
follow
lt
patient
aclf
grade
compar
cohort
surviv
year
main
differ
patient
characterist
studi
collabor
work
incid
respiratori
failur
group
patient
alcf
grade
vs
togeth
data
suggest
sever
uncontrol
respiratori
failur
may
view
contraind
lt
line
recent
report
identifi
sever
acut
respiratori
distress
syndrom
independ
factor
associ
posttranspl
improv
stabil
of
immedi
pretranspl
period
associ
favour
postlt
outcom
patient
aclf
suggest
evolut
of
least
control
improv
consid
lt
anoth
import
point
consid
timefram
lt
studi
report
favour
postlt
outcom
sever
ill
patient
earli
lt
perform
time
placement
wait
list
lt
rang
day
short
timefram
requir
natur
histori
patient
inde
around
die
first
signific
proport
patient
place
wait
list
acut
deterior
condit
exampl
studi
patient
transplant
aclf
grade
place
wait
list
immedi
prelt
hospit
median
time
lt
day
therefor
pretranspl
evalu
must
perform
time
fashion
preclud
number
clinic
test
usual
requir
lt
programm
knowledg
potenti
impact
postlt
outcom
truncat
evalu
yet
studi
extens
patient
high
meld
truncat
evalu
involv
perform
necessari
screen
test
could
lead
potenti
contraind
lt
activ
neoplasia
sever
alcohol
depend
still
signific
coronari
arteri
diseas
overlook
addit
potenti
impact
outcom
rais
degre
unfair
regard
less
sever
patient
undergo
recommend
exhaust
evalu
routin
respons
list
patient
discoveri
contraind
urgent
need
evalu
variou
intern
lt
centr
practic
set
prospect
studi
valid
standard
assess
patient
high
meld
score
yet
list
put
forward
order
optim
select
candid
decreas
inequ
lt
seem
confer
favour
surviv
outcom
sick
patient
associ
longer
total
stay
icu
hospit
also
lead
high
rate
complic
observ
popul
therefor
requir
attent
screen
complic
particularli
infecti
natur
current
knowledg
suggest
transplant
outcom
select
patient
aclf
could
favour
even
patient
multiorgan
failur
time
lt
howev
order
optim
postlt
outcom
lt
perform
time
manner
admiss
within
window
improv
least
stabil
of
order
identifi
transplant
window
class
contraind
separ
first
definit
contraind
respons
immedi
irrevers
arrest
lt
process
local
level
contraind
wide
accept
might
illustr
metastat
solid
neoplasia
sever
cardiac
pulmonari
insuffici
relat
liver
diseas
even
prehospit
bedridden
state
howev
definit
contraind
definit
specif
time
specif
transplant
centr
appreci
vari
lt
centr
depend
local
expertis
potenti
chang
time
within
second
dynam
contraind
respons
short
temporari
inabl
perform
liver
transplant
dynam
contraind
repres
number
diseas
failur
could
evolv
posit
appropri
therapeut
manag
uncontrol
bacteri
infect
activ
fungal
infect
activ
gastrointestin
bleed
sever
acut
respiratori
distress
syndrom
sever
haemodynam
instabl
sever
coagulopathi
dynam
contraind
often
repres
precipit
event
aclf
syndrom
occurr
resolut
control
dynam
contraind
context
stabil
improv
of
defin
transplant
window
fig
discuss
earlier
optim
transplant
window
identifi
soon
possibl
admiss
patient
high
meld
score
consid
poor
expect
outcom
risk
develop
advers
event
dynam
contraind
short
timefram
due
lack
data
field
exact
timefram
within
lt
contraind
dynam
contraind
often
transplant
centr
local
expertis
depend
concept
transplant
window
lt
patient
without
definit
contraind
base
absenc
dynam
contraind
allow
lt
perform
context
stabil
improv
of
transplant
window
rapidli
identifi
follow
admiss
order
optim
postlt
outcom
studi
report
outcom
cirrhot
patient
icu
discharg
scarc
howev
recoveri
critic
ill
cirrhot
patient
higher
risk
mortal
compar
gener
popul
predictor
associ
mortal
icu
discharg
clearli
report
could
relat
number
type
of
patient
experienc
icu
well
sever
liver
diseas
admiss
discharg
current
reliabl
tool
identifi
popul
low
risk
mortal
initi
effect
icu
care
discharg
icu
therefor
patient
refer
liver
transplant
centr
hospit
close
thereaft
order
evalu
lt
even
case
recoveri
liver
function
patient
high
meld
score
admit
context
aclf
refer
lt
centr
soon
possibl
consid
risk
event
popul
modal
serv
bridg
lt
confer
suffici
clinic
improv
enabl
patient
discharg
icuhospit
posit
impact
outcom
patient
high
meld
score
modal
aim
replac
function
fail
liver
allow
hepat
recoveri
stabil
clinic
state
enabl
transplant
key
concept
therapi
remov
harm
toxin
support
liver
spontan
regener
reduc
ongo
inflammatori
base
albumin
dialysi
molecular
adsorb
recircul
system
plasma
separ
absorpt
system
studi
devic
mar
therapi
report
improv
bilirubin
level
hepat
encephalopathi
haemodynam
paramet
kidney
function
patient
decompens
cirrhosi
without
improv
surviv
relief
trial
includ
patient
aclf
improv
transplantfre
surviv
day
helio
studi
despit
welltoler
treatment
prometheu
therapi
report
improv
shortterm
surviv
patient
note
result
interpret
caution
due
heterogen
popul
patient
decompens
cirrhosi
associ
differ
degre
of
differ
definit
result
larg
prospect
multicentr
studi
evalu
bioartifici
devic
extracorpor
cellular
therapi
patient
sever
alcohol
hepat
show
confer
overal
surviv
benefit
compar
standard
care
howev
among
limit
patient
stratifi
accord
respons
medic
treatment
definit
conclus
efficaci
devic
date
second
studi
younger
patient
lower
meld
score
therefor
ongo
current
trial
involv
extracorpor
liver
support
recruit
set
alcf
first
evalu
efficaci
highvolum
plasma
exchang
gcsf
vs
gcsf
alon
patient
aclf
clinicaltrialsgov
identifi
second
multicentr
random
control
studi
evalu
safeti
perform
new
liver
support
devic
call
dialiv
patient
aclf
vs
standard
care
base
result
avail
rct
easl
guidelin
state
extracorpor
liver
support
system
improv
surviv
patient
aclf
therefor
recommend
among
medic
treatment
offer
set
gcsf
seem
promis
treatment
accumul
evid
potenti
efficaci
albeit
small
number
patient
treat
date
gcsf
promot
mobil
hematopoiet
stem
cell
induc
prolifer
hepat
progenitor
cell
anim
model
liver
failur
also
human
alcohol
hepat
smallrandom
clinic
trial
demonstr
improv
liver
function
gcsf
also
signific
surviv
benefit
compar
standard
medic
therapi
aclf
nonetheless
time
insuffici
evid
therapi
recommend
patient
high
meld
score
decis
essenti
perform
accord
local
expertis
belief
specif
point
easl
guidelin
state
despit
promis
result
administr
gcsf
recommend
surviv
probabl
patient
high
meld
score
effici
calcul
avail
score
aclf
aclf
grade
clifc
aclf
absenc
altern
treatment
lt
due
sever
cours
observ
popul
without
lt
withdraw
care
could
reason
option
patient
present
definit
contraind
canon
cohort
sequenti
calcul
score
report
identifi
group
patient
sever
outcom
transplantfre
patient
identifi
of
andor
clifc
aclf
day
day
base
result
algorithm
approach
propos
withdraw
care
retrospect
analysi
perform
king
colleg
use
threshold
report
patient
surviv
highlight
predict
score
perform
differ
differ
cohort
medic
manag
relat
algorithmbas
score
adopt
wide
without
caution
import
recogn
decis
regard
withdraw
irrevoc
small
surviv
probabl
perceiv
differ
caregiv
patient
famili
balanc
aspect
maintain
patient
life
digniti
wish
fraught
statist
ethic
difficulti
singl
score
unlik
final
regard
decis
withdraw
care
data
literatur
well
data
local
experi
consid
alongsid
potenti
improv
of
qualit
factor
frailti
patient
wish
final
opinion
score
use
identifi
situat
could
reason
initi
discuss
around
withdraw
care
easl
guidelin
state
withdraw
ongo
intens
care
support
suggest
patient
candid
lt
of
week
adequ
intens
accur
identif
variabl
associ
mortal
patient
cirrhosi
perman
scarciti
liver
graft
led
lt
recommend
increas
number
sever
ill
patient
consequ
physician
lt
centr
routin
face
medic
surgic
ethic
challeng
nonetheless
data
accumul
pretranspl
manag
patient
refin
diseas
assess
base
variabl
clinic
cours
determin
risk
factor
poor
outcom
lt
may
made
help
defin
sick
transplant
upperlimit
howev
await
devic
treatment
delay
avoid
lt
urgent
need
base
robust
data
offer
consensu
definit
definit
contraind
transplant
window
